| Target
Information |
| Name | Dihydropteroate synthetase |
| Type of target | Successful target |
| Synonyms | DHPS |
| Dihydropteroate pyrophosphorylase |
| Dihydropteroate synthase |
| H2Pte synthase |
| Disease | Bacterial infections [1] |
| Malaria [2][3][4] |
| Drug(s) | Dapsone |  | Approved | Pneumocystis carinii pneumonia | [5] |
| Sulfacytine |  | Approved | Urinary tract infections | [6] |
| Sulfadiazine |  | Approved | Urinary tract infections | [7] |
| Sulfadoxine |  | Approved | Malaria | [8] |
| Sulfamerazine |  | Approved | Bacterial infections | [9] |
| Sulfamethazine |  | Approved | Bacterial infections | [10] |
| Sulfamethizole |  | Approved | Urinary tract infections | [11] |
| Sulfamethoxazole |  | Approved | Bacterial infections | [12] |
| Sulfametopyrazine |  | Approved | Urinary tract infection | [13] |
| Sulfapyridine |  | Approved | Dermatitis herpetiformis | [9] |
| Sulfisoxazole |  | Approved | Urinary tract infections | [14] |
| Sulfonamides |  | Approved | Bacterial infections | [15] |
| Sulphadoxine |  | Approved | Malaria | [16] |
| EC Number | EC 2.5.1.15 |
| UniProt ID | P26282 |
| Q8IAU3 |
| Q93RQ9 |
| Q96W63 |
| Q9BIX9 |
| PDB Structure | 1AJ0; 1AJ2; 1AJZ. |
| Function | Dhps catalyzes the formation of the immediate precursor of folic acid. It is implicated in resistance to sulfonamide. |
| Sequence | MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE
STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL
SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE
KLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIGQLLNVGPSERLSGSL
ACAVIAAMQGAHIIRVHDVKETVEAMRVVEATLSAKENKRYE
|
| Target Validation | Click to Find Target Validation Information. |
| Inhibitor | 2,6-diamino-5-nitropyrimidin-4 (3H)-one |  | [17] |
| 2,6-diamino-5-nitrosopyrimidin-4 (3H)-one |  | [17] |
| 2-amino-8-methyl-7,8-dihydropteridin-4 (3H)-one |  | [17] |
| 6-Methylamino-5-Nitroisocytosine |  | [18] |
| Dapsone |  | [5] |
| Pterin-6-Yl-Methyl-Monophosphate |  | [19] |
| Pteroic Acid |  | [20] |
| Sulfacytine |  | [6] |
| Sulfadiazine |  | [7] |
| Sulfadoxine |  | [8] |
| Sulfamerazine |  | [9] |
| Sulfamethazine |  | [10] |
| Sulfamethizole |  | [11] |
| Sulfamethoxazole |  | [12] |
| Sulfametopyrazine |  | [13] |
| Sulfapyridine |  | [9] |
| Sulfisoxazole |  | [14] |
| [Pterin-6-Yl Methanyl]-Phosphonophosphate |  | [19] |
| Binder | Sulfonamide |  | [1] |
| Sulfonamides |  | [15] |
| Sulphadoxine |  | [16] |
| Sulphameth oxazole |  | [21] |
| Cross References |
3D Structure
Related Literature
On-Line
Medical Dictionary |
| Ref 1 | Resistance to trimethoprim and sulfonamides. Vet Res. 2001 May-Aug;32(3-4):261-73. To Reference |
| Ref 2 | Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol Microbiol. 1999 Jun;32(6):1254-62. To Reference |
| Ref 3 | In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. J Infect Dis. 1998 May;177(5):1429-33. To Reference |
| Ref 4 | Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994 Sep 1;224(2):397-405. To Reference |
| Ref 5 | Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis. FEMS Microbiol Lett. 2008 Oct;287(1):128-35. Epub 2008 Aug 1. To Reference |
| Ref 6 | Sulfacytine in uncomplicated urinary tract infections. Double-blind comparison with sulfisoxazole. Urology. 1976 Mar;7(3):267-71. To Reference |
| Ref 7 | Sulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling. Bioorg Med Chem. 2008 May 15;16(10):5788-94. Epub 2008 Mar 27. To Reference |
| Ref 8 | Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand. Am J Trop Med Hyg. 2008 Mar;78(3):462-7. To Reference |
| Ref 9 | A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry according to Commission Decision 2002/657/EC. J Chromatogr A. 2009 Jun 9. [Epub ahead of print] To Reference |
| Ref 10 | A new and simple method to determine trace levels of sulfonamides in honey by high performance liquid chromatography with fluorescence detection. J Chromatogr A. 2009 May 29. [Epub ahead of print] To Reference |
| Ref 11 | Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine. Biochim Biophys Acta. 1990 Jun 26;1017(3):229-34. To Reference |
| Ref 12 | In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Antimicrob Agents Chemother. 1995 Apr;39(4):948-52. To Reference |
| Ref 13 | Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study. Indian J Malariol. 2001 Sep-Dec;38(3-4):76-83. To Reference |
| Ref 14 | Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63.Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. To Reference |
| Ref 15 | Has nature already identified all useful antibacterial targets? Curr Opin Microbiol. 2008 Oct;11(5):387-92. Epub 2008 Oct 6. To Reference |
| Ref 16 | The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs. Curr Med Chem. 2008;15(2):161-71. To Reference |
| Ref 17 | J Med Chem. 2010 Jan 14;53(1):166-77.Structural studies of pterin-based inhibitors of dihydropteroate synthase. To Reference |
| Ref 18 | Nucleic Acids Res. 2011 January; 39(Database issue): D1035¨CD1041. DrugBank 3.0: a comprehensive resource for ¡®Omics¡¯ research on drugs To Reference |
| Ref 19 | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. To Reference |
| Ref 20 | Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. To Reference |
| Ref 21 | Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov. 2005 Sep;4(9):727-40. To Reference |